Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of enzastaurin and pemetrexed
can extend survival time without progression of disease for participants who have advanced or
metastatic non-small cell lung cancer (NSCLC).